Medical Billing Consulting for Infectious Disease Practices

A medical billing consultant helps a healthcare practice understand and improve the financial processes connecting clinical work to reimbursement. For an infectious disease practice, that can include documentation, coding, eligibility, prior authorization, drug and infusion billing, claims, denials, payment reconciliation, contract compliance, and A/R follow-up. A consultant may assess the workflow, identify revenue leakage or delays, and provide a prioritized plan for operational improvement.

Consulting can help an infectious disease practice examine whether its billing workflow captures the work being performed and supports timely reimbursement. The review may cover office visits, hospital consults, infusion, OPAT, specialty drugs, authorization, denials, underpayments, and aging claims. The goal is to connect each issue to its operational cause so the practice can make informed improvements rather than rely on generalized rates or assumptions.

Common challenges include under-documented consults, missed drug or administration charges, authorization problems, confusion between medical and pharmacy benefits, coding issues, rejected claims, payer underpayments, and aging infusion or hospital consult claims. Independent practices may also need to coordinate several revenue streams and service locations. Reviewing these areas together can reveal where revenue is delayed, lost, or left uncollected.

Yes. Infectious disease revenue-cycle consulting can examine the workflow for infusion and OPAT services from referral and eligibility through authorization, drug acquisition, administration billing, claim submission, payment, and follow-up. The review can also consider whether the practice has appropriate enrollment and operational processes for each service. This helps distinguish clinical workflow issues from billing, payer, or documentation problems.

A revenue-cycle review can cover documentation and coding, charge capture, eligibility, prior authorization, drug and infusion billing, claims submission, denials, underpayments, A/R follow-up, and payer or hospital coverage agreements. The review follows the path from referral to final payment and identifies where revenue is delayed or missed. Findings can then be organized into a practical plan based on the practice’s own operations and numbers.

Denials can be grouped by root cause, payer, service type, and workflow stage. Relevant causes may include missing authorization, medical versus pharmacy benefit issues, drug or administration coding, and insufficient consult documentation. Payer-specific appeals can be supported by the available clinical documentation, while recurring findings can be shared with clinical, coding, and front-office teams to reduce repeat problems.

Yes. Payment reconciliation compares received reimbursement with the expected payment for drug, administration, and evaluation and management claims. The review may identify short-pays, incorrect fee schedule application, unit discrepancies, NDC mismatches, or contract-compliance concerns. Findings can be tracked for dispute and recovery, while recurring patterns may inform discussions about payer agreements and renewal terms.

The service is relevant to infectious disease physicians, independent infectious disease practices, group leaders, and medical practice administrators. It can be useful when launching an infusion suite or OPAT program, adding providers, reviewing claims performance, investigating unexplained collection differences, or assessing whether current processes support the work being performed. Practices can apply the guidance to their own operational and financial information.